☰

Empresas y finanzas

BIO-Europe 2006 - November 6-8, 2006 Congress Center, Dusseldorf, Germany


    Dr. Jurgen Ruttgers, the Minister President of the State of
    Nordrhein-Westfalen (NRW), will be addressing the conference on his
    plans to develop the region as a biotech hub. Dr. Ruttgers is arguably
    Germany's leading political figurehead for the life science sector. In
    the mid 1990s, as Germany's Minister of Science and Technology, he was
    responsible for devising and executing Germany's BioRegio programme,
    which laid the foundations for Germany's thriving biotech sector
    today.

    Additionally, Jim Greenwood, President of BIO, will be announcing
    a new coalition to support development of the Food and Drug
    Administration (FDA), the US body that approves new drugs. "We have
    come together as a broad and diverse coalition to call for a renewed
    public commitment for the FDA. The agency needs increased support in
    order to continue its mission as it faces a revolutionary new era of
    scientific innovation and advancement. Renewed support also will help
    enable the agency to continue its historic global leadership as the
    `gold standard' for regulatory science and consumer protection."

    Dusseldorf's Lord Mayor, Joachim Erwin, will address the
    conference highlighting that he sees BIO-Europe's choice of location
    as a vote of confidence in the city as a life science location. On
    Sunday 5th November, the North Rhine-Westphalia state capital
    Dusseldorf will be hosting a welcome reception for all participants of
    the conference.

    Also making an announcement at the conference, Peer Schatz and his
    team at Qiagen will be holding a press briefing dedicated to "Setting
    Standards in Biomedical Tissue Management". This will address the
    current difficulties seen in lack of standardization in the
    preparation of biological samples through collection, stabilisation,
    and homogenisation of a sample; its identification, tracking and
    storage; and the purification of analytes such as DNA, RNA, and
    protein.

    BIO-Europe, and its new sister conference BIO-Europe Spring, has a
    dedicated press office to disseminate news, stories, and conference
    themes directly to journalists in advance of the conference and as
    they develop and evolve at the conference. This year there will be
    more media briefings and opportunities for one-on-one meetings.

    At last year's BIO-Europe in Dresden, Germany, the number of
    delegates topped 1450, from more than 850 companies, representing 34
    countries. There were 167 biotech company presentations, a host of
    international exhibitors, and 5124 scheduled one-on-one partnering
    meetings.

    BIO-Europe 2006 is co-hosted by the Biotechnology Industry
    Organization (BIO) and EBD Group in partnership with European
    Biopharmaceutical Enterprises (EBE).

    Media registration at BIO-Europe 2006 is complimentary.

    Please visit the conference website at
    www.ebdgroup.com/bioeurope for detailed information on this year's
    event and online registration.